Improved effects of viral gene delivery of human uPA plus biliodigestive anastomosis induce recovery from experimental biliary cirrhosis (Q39385176)

11 September 2017

Improved effects of viral gene delivery of human uPA plus biliodigestive anastomosis induce recovery from experimental biliary cirrhosis (English)

1 reference

11 September 2017

0 references

Alejandra Miranda-Díaz

1

1 reference

11 September 2017

Ana Rosa Rincón

2

1 reference

11 September 2017

Silvia Salgado

3

1 reference

11 September 2017

José Vera-Cruz

4

1 reference

11 September 2017

Javier Gálvez

5

1 reference

11 September 2017

Ma Cristina Islas

6

1 reference

11 September 2017

Jaime Berumen

7

1 reference

11 September 2017

Estuardo Aguilar-Cordova

8

1 reference

11 September 2017

Juan Armendáriz-Borunda

9

1 reference

11 September 2017

1 January 2004

1 reference

11 September 2017

1 reference

11 September 2017

9

1 reference

11 September 2017

1

1 reference

11 September 2017

30-37

1 reference

Liver transplantation (1).

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.015

Liver transplantation in pediatrics: indications, contraindications, and pretransplant management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.015

Chronic cholestatic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.015

Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.015

7 January 2021

Biliary reconstruction.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.015

A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.015

Sustained biochemical and histologic remission of primary biliary cirrhosis in response to medical treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.015

Reversibility of secondary biliary fibrosis by biliodigestive anastomosis in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.015

Viral gene delivery of superoxide dismutase attenuates experimental cholestasis-induced liver fibrosis in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.015

Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.015

A Modified Urokinase Plasminogen Activator Induces Liver Regeneration Without Bleeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.015

Sensitivity and reproducibility in adenoviral infectious titer determination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.015

Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.015

A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.015

Cholestasis-induced fibrosis is reduced by interferon alpha-2a and is associated with elevated liver metalloprotease activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.015

In vivo surgical resection plus adjuvant gene therapy in the treatment of mammary and prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.015

Enhanced therapeutic effect of HSV-tk+GCV gene therapy and ionizing radiation for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.015

Long-term results with the Kasai operation for biliary atresia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.015

Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.015

Long-term results of biliary reconstruction after laparoscopic bile duct injuries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.015

Portoenterostomy: an old treatment for a new disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.015

Prognosis in primary biliary cirrhosis: model for decision making

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.015

Survival after first esophageal variceal hemorrhage in patients with biliary atresia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.015

Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.015

Serum bilirubin: a prognostic factor in primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.015

Mutation in collagen-1 that confers resistance to the action of collagenase results in failure of recovery from CCl4-induced liver fibrosis, persistence of activated hepatic stellate cells, and diminished hepatocyte regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.015

Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.09.015

10.1016/J.YMTHE.2003.09.015

7 January 2021

Identifiers

DOI

1 reference

11 September 2017

1 reference